Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Comparing Menghini-type Needle and Franseen-type Needle in EBUS-TBNA for Sarcoidosis

NCT: NCT06220526 · RECRUITING

NCT IDNCT06220526
StatusRECRUITING
Start Date2023-08-18
Completion2027-02-28

Brief Summary

This randomized pilot clinical trial aims to examine whether sample collection with Franseen-type needles are effective for the diagnosis of sarcoidosis, as defined by improved sample quality for pathological diagnosis compared to the conventional Menghini-type needle.

Frequently Asked Questions

What is Comparing Menghini-type Needle and Franseen-type Needle in EBUS-TBNA for Sarcoidosis?

Comparing Menghini-type Needle and Franseen-type Needle in EBUS-TBNA for Sarcoidosis is a clinical trial registered under NCT06220526. Current status: RECRUITING.

What is the status of NCT06220526?

The current status of NCT06220526 (Comparing Menghini-type Needle and Franseen-type Needle in EBUS-TBNA for Sarcoidosis) is: RECRUITING.

When did Comparing Menghini-type Needle and Franseen-type Needle in EBUS-TBNA for Sarcoidosis start?

Comparing Menghini-type Needle and Franseen-type Needle in EBUS-TBNA for Sarcoidosis started on 2023-08-18.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑